Literature DB >> 18266747

White matter angiopathy is common in pediatric patients with intractable focal epilepsies.

Michelle Hildebrandt1, Kerstin Amann, Rolf Schröder, Tom Pieper, Dieter Kolodziejczyk, Hans Holthausen, Michael Buchfelder, Hermann Stefan, Ingmar Blümcke.   

Abstract

PURPOSE: The blood-brain barrier (BBB) and functional organization of blood vessels is severely affected in many epilepsy disorders. This was repetitively shown with respect to the cause, effect and treatment of seizures. In the present study, we investigated pathomorphological abnormalities of blood vessels in a cohort of young patients with chronic intractable seizures submitted to an epilepsy surgery program.
METHODS: Histopathological examination was performed in surgical specimens obtained from 87 children with intractable epilepsies. Immunohistochemistry was employed to further characterize the basal membrane as well as specific cellular and tissue reactions. Pathological findings were correlated with clinical data including antiepileptic drug prescription.
RESULTS: We identified an intriguing pattern of white matter angiopathy in 64.4% of our patient cohort. Major alterations included splitting of the basal membrane into endothelial and parenchymal leaves, which was restricted to arterioles and capillaries of the white matter and resulted in an extensively enlarged perivascular space. These cavities contained numerous blood cells and showed a spongiform appearance at the ultrastructural level. Angiopathic changes occurred independent from specific epilepsy-associated lesions, i.e., dysplasia, neoplasia, or hippocampal sclerosis, and showed no correlation with antiepileptic drug treatment or seizure semiologies. DISCUSSION: A high frequency of spongiform white matter angiopathy was identified in young patients with chronic epilepsies. The severity of basal membrane pathology and adjacent tissue reaction is compatible with compromised BBB function. Further clinicopathological investigations will be mandatory to clarify its relation to the cause or consequence of seizures in children with intractable seizures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266747     DOI: 10.1111/j.1528-1167.2007.01514.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

Review 1.  Use of peripheral blood transcriptome biomarkers for epilepsy prediction.

Authors:  Stanislav L Karsten; Lili C Kudo; Anatol J Bragin
Journal:  Neurosci Lett       Date:  2011-03-17       Impact factor: 3.046

Review 2.  Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy.

Authors:  Hadas Han; Aniv Mann; Dana Ekstein; Sara Eyal
Journal:  AAPS J       Date:  2017-05-26       Impact factor: 4.009

Review 3.  Molecular cascades that mediate the influence of inflammation on epilepsy.

Authors:  Alon Friedman; Ray Dingledine
Journal:  Epilepsia       Date:  2011-05       Impact factor: 5.864

4.  Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report.

Authors:  Stefano Sotgiu; Maria R Murrighile; Gabriela Constantin
Journal:  BMC Neurol       Date:  2010-09-23       Impact factor: 2.474

5.  Reduced ratio of afferent to total vascular density in mesial temporal sclerosis.

Authors:  Ryan T Mott; Clara R Thore; Dixon M Moody; Steven S Glazier; Thomas L Ellis; William R Brown
Journal:  J Neuropathol Exp Neurol       Date:  2009-10       Impact factor: 3.685

Review 6.  Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?

Authors:  G Curia; C Lucchi; J Vinet; F Gualtieri; C Marinelli; A Torsello; L Costantino; G Biagini
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

7.  Time and age dependent regulation of neuroinflammation in a rat model of mesial temporal lobe epilepsy: Correlation with human data.

Authors:  Sinem Erisken; George Nune; Hyokwon Chung; Joon Won Kang; Sookyong Koh
Journal:  Front Cell Dev Biol       Date:  2022-09-13

Review 8.  Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

Authors:  Pavel Klein; Raymond Dingledine; Eleonora Aronica; Christophe Bernard; Ingmar Blümcke; Detlev Boison; Martin J Brodie; Amy R Brooks-Kayal; Jerome Engel; Patrick A Forcelli; Lawrence J Hirsch; Rafal M Kaminski; Henrik Klitgaard; Katja Kobow; Daniel H Lowenstein; Phillip L Pearl; Asla Pitkänen; Noora Puhakka; Michael A Rogawski; Dieter Schmidt; Matti Sillanpää; Robert S Sloviter; Christian Steinhäuser; Annamaria Vezzani; Matthew C Walker; Wolfgang Löscher
Journal:  Epilepsia       Date:  2017-12-15       Impact factor: 5.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.